AIGEN INVESTMENT MANAGEMENT, LP – Neurocrine Biosciences, Inc. Transaction History
AIGEN INVESTMENT MANAGEMENT, LP portfolio value:
$2.67M
portfolio value
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | 0.00% | 25.15K shares | 2.67M | $106.21 | 25.15K |
| Q1 2022 | share | Decrease | -100.00% | -2.83K shares | -233K | $93.75 | 0 |
| Q4 2021 | share | Increase | 0.00% | 2.83K shares | 233K | $84.63 | 2.83K |
| Q3 2021 | share | Decrease | -100.00% | -7.80K shares | -760K | $95.91 | 0 |
| Q2 2021 | share | Increase | +43.81% | 2.37K shares | 232K | $97.32 | 7.80K |
| Q1 2021 | share | Increase | 0.00% | 5.42K shares | 528K | $97.25 | 5.42K |
| Q4 2020 | share | Decrease | -100.00% | -6.93K shares | -667K | $95.85 | 0 |
| Q3 2020 | share | Increase | +94.04% | 3.36K shares | 231K | $96.16 | 6.93K |
| Q2 2020 | share | Decrease | -54.88% | -4.34K shares | -250K | $122 | 3.57K |
| Q1 2020 | share | Decrease | -14.78% | -1.37K shares | -313K | $86.55 | 7.92K |
| Q4 2019 | share | Increase | 0.00% | 9.29K shares | 999K | $107.49 | 9.29K |